infektiopod

infektiopod is a German infectious-disease podcast built around clinical reasoning, current research, and the practical consequences of evidence. It is technical by design. The show treats infections as problems with mechanisms, histories, diagnostic blind spots, treatment costs, guideline habits, and imperfect data rather than as tidy explainer topics. Recent episodes cover ESCMID news on bloodstream infections and AI, endemic systemic mycoses, sepsis immunology, HIV therapy, tuberculosis studies, dalbavancin, and Stenotrophomonas maltophilia. The rhythm is conversational, but the vocabulary is unapologetically specialist. A topic may begin with a clinical question, move into taxonomy or immunology, pause for a trial design detail, then return to the patient-facing decision that motivated the discussion in the first place. That structure gives the show its value. It does not flatten uncertainty into quick advice. In the episode on AI and health, for example, the discussion focuses on constructed case examples, bias, context variables, and the danger of uneven recommendations from large language models. In the mycoses episode, a guest-led section tracks environmental presence, European exposure, imported human cases, travel history, reactivation, and parallels with tuberculosis. The sepsis immunology discussion gets granular about HLA-DR, thresholds, immune suppression, and possible immune stimulation. HIV therapy is treated historically as well as clinically, with attention to when treatment thresholds changed and how adherence is discussed with patients. The English-language Stenotrophomonas episode shows the same method in another register: preclinical models, limited human data, cefidericol, trim sulfa, minocycline, levofloxacin, and the problem of making choices without one-size-fits-all certainty. The tone is collegial and restrained. Guests are allowed room to explain. The regular speakers ask pointed follow-ups rather than forcing brisk summaries. The show is best for listeners who can tolerate long, evidence-dense reasoning and who find clinical nuance more useful than dramatic certainty. It is not casual health content. It is infectious-disease audio for people who want the messy middle between paper, guideline, and ward.